MENU
+Compare
CODX
Stock ticker: NASDAQ
AS OF
Jun 11 closing price
Price
$0.29
Change
-$0.00 (-0.00%)
Capitalization
34.7M

CODX Co-Diagnostics Forecast, Technical & Fundamental Analysis

Co-Diagnostics Inc is a molecular diagnostics company... Show more

Industry: #Biotechnology
CODX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CODX with price predictions
Jun 10, 2025

CODX's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for CODX turned positive on June 03, 2025. Looking at past instances where CODX's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CODX's RSI Indicator exited the oversold zone, of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 69 cases where CODX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 04, 2025. You may want to consider a long position or call options on CODX as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CODX advanced for three days, in of 221 cases, the price rose further within the following month. The odds of a continued upward trend are .

CODX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CODX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.403) is normal, around the industry mean (24.242). P/E Ratio (6.165) is within average values for comparable stocks, (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (4.782) is also within normal values, averaging (42.497).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CODX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CODX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
CODX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CODX is expected to report earnings to rise 175.00% to -66 cents per share on August 07

Co-Diagnostics CODX Stock Earnings Reports
Q2'25
Est.
$-0.66
Q1'25
Beat
by $0.10
Q4'24
Missed
by $0.03
Q3'24
Beat
by $0.01
Q2'24
Beat
by $0.09
The last earnings report on May 08 showed earnings per share of -23 cents, beating the estimate of -34 cents. With 177.37K shares outstanding, the current market capitalization sits at 34.70M.
A.I. Advisor
published General Information

General Information

a developer of molecular diagnostics products and tests that represents a radical new advancement in the understanding of the molecular interactions of DNA

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2401 South Foothill Drive
Phone
+1 801 438-1036
Employees
155
Web
https://www.codiagnostics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MOD94.152.22
+2.41%
Modine Manufacturing Co
CGAU7.05N/A
N/A
Centerra Gold
HUM231.74-0.24
-0.10%
Humana
RFIL4.12-0.09
-2.14%
RF Industries Ltd
OLMA4.08-0.13
-3.09%
Olema Pharmaceuticals

CODX and Stocks

Correlation & Price change

A.I.dvisor tells us that CODX and ALGN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CODX and ALGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CODX
1D Price
Change %
CODX100%
+1.17%
ALGN - CODX
32%
Poorly correlated
-1.38%
ILMN - CODX
30%
Poorly correlated
-0.50%
AEMD - CODX
29%
Poorly correlated
+1.51%
NVST - CODX
26%
Poorly correlated
+0.47%
AIMD - CODX
26%
Poorly correlated
-6.07%
More